CHIODERA, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 11.013
AS - Asia 9.571
EU - Europa 6.086
SA - Sud America 1.073
AF - Africa 453
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 13
AN - Antartide 1
Totale 28.229
Nazione #
US - Stati Uniti d'America 10.701
SG - Singapore 3.678
CN - Cina 2.724
VN - Vietnam 1.356
FI - Finlandia 1.240
IE - Irlanda 1.126
SE - Svezia 914
DE - Germania 879
BR - Brasile 833
HK - Hong Kong 666
UA - Ucraina 572
TR - Turchia 478
ZA - Sudafrica 360
IT - Italia 295
NL - Olanda 292
FR - Francia 290
CA - Canada 237
GB - Regno Unito 142
IN - India 139
AR - Argentina 85
RU - Federazione Russa 85
BD - Bangladesh 74
IQ - Iraq 63
BE - Belgio 50
MX - Messico 45
PL - Polonia 44
EC - Ecuador 41
PH - Filippine 40
JP - Giappone 37
PK - Pakistan 37
ES - Italia 33
ID - Indonesia 32
VE - Venezuela 31
KR - Corea 26
TH - Thailandia 26
SA - Arabia Saudita 24
AT - Austria 23
UZ - Uzbekistan 23
IR - Iran 22
CO - Colombia 21
CI - Costa d'Avorio 20
CL - Cile 19
LT - Lituania 19
EU - Europa 18
PE - Perù 17
AZ - Azerbaigian 16
KE - Kenya 15
MA - Marocco 15
PY - Paraguay 15
EG - Egitto 14
IL - Israele 11
MY - Malesia 11
TW - Taiwan 11
AL - Albania 9
AU - Australia 9
CZ - Repubblica Ceca 9
JO - Giordania 9
NO - Norvegia 9
HU - Ungheria 8
KG - Kirghizistan 7
LU - Lussemburgo 7
NP - Nepal 7
OM - Oman 7
PA - Panama 7
UY - Uruguay 7
DO - Repubblica Dominicana 6
DZ - Algeria 6
KZ - Kazakistan 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
BH - Bahrain 5
LB - Libano 5
PS - Palestinian Territory 5
TN - Tunisia 5
BO - Bolivia 4
ET - Etiopia 4
JM - Giamaica 4
LK - Sri Lanka 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
AM - Armenia 3
AO - Angola 3
CH - Svizzera 3
DK - Danimarca 3
HN - Honduras 3
MN - Mongolia 3
SY - Repubblica araba siriana 3
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CR - Costa Rica 2
GT - Guatemala 2
HR - Croazia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
NG - Nigeria 2
SN - Senegal 2
ZW - Zimbabwe 2
AG - Antigua e Barbuda 1
Totale 28.204
Città #
Singapore 1.940
Ashburn 1.583
Chandler 1.284
Jacksonville 1.156
Dublin 1.122
San Jose 777
Santa Clara 747
Beijing 727
Hong Kong 641
Dallas 617
Dearborn 440
Izmir 439
Ho Chi Minh City 429
Johannesburg 344
Nanjing 338
Hanoi 318
Boardman 263
San Mateo 254
Princeton 234
Lauterbourg 207
Toronto 178
Los Angeles 176
Shanghai 170
Munich 140
Ann Arbor 138
Des Moines 132
Nanchang 127
Shenyang 119
Düsseldorf 116
Helsinki 108
Wilmington 108
Kunming 103
New York 89
Woodbridge 76
Columbus 74
Hebei 69
Jinan 66
Haiphong 65
São Paulo 63
Buffalo 58
Hefei 58
Moscow 56
Tianjin 56
Brussels 50
Leawood 48
Grafing 47
Guangzhou 47
Da Nang 46
Turku 44
Seattle 39
Parma 38
Changsha 37
Jiaxing 37
London 35
Tokyo 32
Warsaw 32
Redondo Beach 30
Atlanta 29
Rome 29
Chennai 28
Brooklyn 26
Hangzhou 26
Campinas 24
Chicago 24
Falkenstein 24
Hải Dương 24
Pune 24
Phoenix 23
Zhengzhou 23
Baghdad 22
Orem 22
Augusta 21
Biên Hòa 21
Monmouth Junction 21
Rio de Janeiro 21
Abidjan 20
Amsterdam 20
Denver 20
Stockholm 19
Tashkent 19
Bremen 17
Dhaka 17
Ottawa 17
Fremont 16
Fuzhou 16
Mumbai 16
Nuremberg 16
Poplar 16
Ardabil 15
Belo Horizonte 15
Can Tho 15
Frankfurt am Main 15
Manchester 15
Ninh Bình 15
Milan 14
Porto Alegre 14
San Francisco 14
Taizhou 14
Borås 13
Kocaeli 13
Totale 17.600
Nome #
Different effects of aging on the opioid mechanisms controlling gonadotropin and cortisol secretion in man. 376
Livelli di prolattina, deidroepiandrosterone solfato, cortisolo, testosterone e 17-beta-estradiolo nell'alcolismo cronico. 198
Gonadotropine, prolattina e tireotropina nella S. di Klinefelter. 172
Alpha2-adrenergic and histamine H1 and H2-receptors do not mediate arginine-vasopressin release in response to insulin induced hypoglycemia in man. 171
Inhibition by somatostatin of LH-RH-induced LH release in normal menstruating women. 170
5-HT3 serotonergic receptor mediation of hypoglycemia-induced arginine-vasopressin but not oxytocin secretion in normal men. 170
Studio parallelo di gonadotropine e prolattina in pazienti amenorroiche. 170
Abnormal arginine vasopressin response to cigarette smoking and metoclopramide, but not insulin induced hypoglycemia in elderly subjects. 166
Inhibitory effect of somatostatin on the NPY response to insulin-induced hypoglycemia and the role of endogenous opioids 165
5HT1-, but not 5HT2- serotonergic or M1-, M2-muscarinic cholinergic or dopaminergic receptors mediate the ACTH/cortisol response to metoclopramide. 163
Different effect of metoclopramide and domperidone on GH release in type 1 male diabetics. 162
Abnormal growth hormone and cortisol but not thyroid stimulating hormone response to an intravenous glucose tolerance test in normal weight bulimic women. 162
Abnormal arginine vasopressin responses to metoclopramide and insulin induced hypoglycemia in type I diabetes mellitus. 160
Abnormal plasma oxytocin and b-endorphin levels in alcoholics after short and long-term abstinence. 160
: Beta-endorphin, ACTH and cortisol secretion rhythms in abstinent alcoholics. 160
ADRENOCORTICOTROPIC HORMONE/CORTISOL RESPONSE TO PHYSICAL EXERCISE IN ABSTINENT ALCOHOLIC PATIENTS 160
Protein Kinase Cε Regulates Proliferation and Cell Sensitivity to TGF-1β of CD4+ T Lymphocytes: Implications for Hashimoto Thyroiditis 159
Sugli effetti di un trattamento policorticoide su gonadotropine, PRL e TSH (valori basali e risposta ipofisaria). 158
Naloxone decreases the inhibitory effect of somatostatin on GH release induced by cigarette smoking in man 158
Effect of muscarinic and nicotinic-cholinergic blockade on the glucagon response to insulin-induced hypoglycemia in normal men. 157
Oxytocin reduces angiotensin II-induced ACTH release in men. 156
Comportamento del settore gonadotropinico nella patologia espansiva diencefalo-ipofisaria prima e dopo trattamento neurochirurgico. 155
Arginine vasopressin secretion in non obese women with polycystic ovary syndrome. 155
Alterazione del controllo oppioide delle gonadotropine, ma non del cortisolo nell'uomo anziano. 155
Glucagon response to insulin-induced hypoglycemia in obese men. 154
Dopaminergic, but not cholinergic involvement in regulation of hypoglycemia-induced oxytocin release in man. 153
Oxytocin administration does not alter growth hormone response to insulin induced hypoglycemia in normal men. 152
ACTH and Beta-Endorphin responses to physical exercise in adolescent women tested for anxiety and frustration 151
The growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics involves a cholinergic mechanism. 151
Age-related decreased in the opioid control of LH secretion during reproductive years in normal men. 151
Considerazioni sul comportamento della prolattina nelle displasie prostatiche. 151
The infusion of somatostatin reduces the arginine vasopressin response to insulin induced hypoglycemia in man. 151
Age-related changed in growth hormone (GH) secretion in normally cycling women. 150
Gonadotropins, prolactin and thyrotropin (basal value and pituitary responses) in infertile male patients. 150
GLUCORECEPTORS LOCATED IN THE BRAIN MEDIATE NPY RELEASE INDUCED BY HYPOGLICEMIA IN NORMAL MEN 149
Lysine-vasopressin inhibits the effect of oxytocin on the insulin response to glucose in normal man. 149
Gn-RH test for hypogonadic men. 148
Alterata risposta secretiva del GH allo stimolo GABAergico nel morbo di Parkinson. 147
LH, FSH, TSH and PRL (basal values and pituitary responses) in oligo- and azospermic patients. 146
Histaminergic H1 and H2 receptors do not mediate cortisol release in response to naloxone in normal men. 145
Different effects of baclofen on LH and cortisol responses to naloxone in normal men. 145
Effect of oxytocin on growth hormone (GH) secretion in response to arginin-vasopressin. 144
Effect of serotonergic system on AVP secretion induced by physical exercise 144
Effect of potentiation of cholinergic tone by pyridostigmine on the growth hormone (GH) response to GH-releasing hormone in elderly men. 143
Iperresponsività nell'anziano dell'arginin-vasopressina a stimolazione con fumo di sigaretta o con metoclopramide, ma non con ipoglicemia insulinica. 142
Effect of lysine vasopressin on basal and TRH stimulated TSH and PRL release in normal men. 141
Stimulatory effect of naloxone on plasma cortical in humans: possible direct stimulatory action at the adrenal cortex. 140
Failure of metergoline to antagonize naloxone induced cortisol rise in man. 138
Arginine Vasopressin and Oxytocin responses to angiotensin II are mediated by AT1 receptor subtype in normal men 138
Influenza dell'età sulla responsività ipofisaria GH- e ACTH-secernente alla lisin vasopressina. 138
Oxytocin does not modify glucagon- or calcitonin induced ACTH/Cortisol rise in humans. 137
Effect of Naloxone on the LH response to intravenously-infused substance P in normal men 137
Effect of metoclopramide on serum GH levels in normal women. 137
Cholinergic- muscarinic-receptors participate in growth hormone secretion induced by lysine-8-vasopressin in man. 137
TSH and PRL responses to domperidone and TRH in men with insulin-dependent diabetes mellitus of different duration. 136
Intravenously infused Substance P is unable to change basal and TRH-stimulated PRL secretion in normal men. 136
Lysine-vasopressin does not affect basal and LH-RH stimulated LH and FSH release during the menstrual cycle of normal women. 136
Patologia espansiva ipotalamo-ipofisaria: studio parallelo di TSH e PRL. 136
Effect of pharmacological doses of oxytocin on insulin response to glucose in man. 136
Increased Arginine-Vasopressin Response to Hypertonic Stimulation and Upright Posture in Idiopathic Hyperprolactinemia 135
Iperresponsività nell'anziano dell'arginin-vasopressina a stimolazione con fumo di sigaretta o con metoclopramide, ma non con ipoglicemia insulinica. 135
Cholinergic mediation of growth hormone secretion induced by thyrotropin-releasing hormone in cirrhotic patients. 135
Risposta di TSH e PRL al TRH nella patologia nodulare tiroidea 135
Abnormal effect of cigarette smoking on pituitary hormone secretions in insulin-dependent diabetes mellitus. 134
Effect of naloxone on oxytocin-induced cortisol decrease in normal men. 134
Effect of histaminergic H1- and H2-receptor antagonist on neurophysin release in response to nicotine from cigarette smoking in normal men. 134
Growth hormone responses to GHRH, clonidine and insulin-induced hypoglycemia in normal weight bulimic women. 134
Effect of naloxone on the inhibitory effect of melatonin on the release of arginine-vasopressin induced by physical exercise in man 133
Age-dependent decrease in the growth hormone (GH) response to GH releasing hormone in normally cicling women. 133
Profili ormonali della sindrome premestruale 133
Influence of residual C-peptide secretion on the arginine-vasopressin response to hypoglycemia and metergoline in insulin-dependent diabetes. 133
Nicotinic-cholinergic involvement in arginine-vasopressin response to insulin-induced hypoglycemia in normal men. 132
La somministrazione endovenosa di ossitocina non determina variazioni nelle concentrazioni di prolattina, TSH e GH in un gruppo di soggetti di sesso maschile. 132
Endogenous opioid mediation of the inhibitory effect of ethanol on the prolactin response to breast stimulation in normal women. 132
Alteration in dopaminergic function in abstinent alcoholics. 132
Effect of nitric oxide on basal and TRH- or metoclopramide-stimulated prolactin release in normal men 132
Circadian vairiations in plasma ACTH, cortisol and beta-endorphin levels in normal weight bulimic women. 132
Arginine-vasopressin (AVP) responses to osmotic, pressure-volumetric and hypoglycemic stimuli in women with polycistic ovaries (PCO) 132
Reduction of lysine vasopressin induced GH, but not ACTH release in elderly men. 132
Naloxone decreases the inhibitory effect of alprazolam on the release of adrenocorticotropin/cortisol induced by physical exercice in man 131
Effect of systemic oxytocin administration on dexamethasone-induced leptin secretion in normal and obese men. 131
Hypoglycemia induced arginine vasopressin and oxytocin release is mediated by glucoreceptors located inside the blood brain barrier 131
Effect of naloxone on neurophysin secretion in normal women. 130
Effect of cimetidine on PRL secretion in elderly subjects. 130
The gabaergic control of prolactin release is not affected by insulin-dependent diabetes mellitus: evidence from studies with sodium valproate. 130
Dopaminergic and opioid receptor antagonist do not modify the secretory response of growth hormone to lysine-vasopressin in normal subjects. 130
Effect of residual endogenous insulin secretion on the abnormal oxytocin response to hypoglycemia in insulin-dependent diabetics. 129
Antiserotonergic and antihistaminergic agents do not antagonize naloxone-induced cortisol secretion in normal men. 127
Inhibition of growth hormone secretion in mild primary hyperparathyroidism 126
Inhibition by oxytocin of Endothelin-1-induced ACTH secretion in normal men. 126
Livelli di deidroepiandrosterone urinario in un gruppo di pazienti di sesso maschile portatori di iperprolattinemia di tipo funzionale. 126
TSH and PRL responses to domperidone in men with insulin-dependent diabetes mellitus (IDDM) 126
Somatostatin reduces Neuropeptide Y rise induced by physical exercise. 125
Stimulatory effect of naloxone on plasma cortisol in human: possible direct stilulatory action at the adrenal cortex 125
Endogenous opioids modulate the oxytocin response to insulin induced hypoglycaemia and partially mediate the inhibitory effect of ethanol in man. 125
Effetto della somministrazione di ossitocina sulla secrezione di prolattina nella donna normale. 125
Luteinizing hormone response to an intravenous infusion of substance P in normal men. 125
Oxytocin response to insulin-induced hypoglycaemia in obese subjects before and after weight loss. 125
Naloxone decreases the inhibiting effect of ethanol on the release of arginine-vasopressin induced by cigarette smoking in man. 124
Prolattina ed osmoregolazione del liquido amniotico. 124
Totale 14.512
Categoria #
all - tutte 92.064
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.064


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021499 0 0 0 0 0 0 0 0 0 23 456 20
2021/20221.127 7 28 4 19 23 56 168 208 53 81 63 417
2022/20234.136 460 403 299 318 310 502 19 285 1.408 17 91 24
2023/20241.405 88 170 23 42 106 234 43 365 33 40 119 142
2024/20254.643 86 272 367 230 480 695 30 206 474 427 407 969
2025/20269.925 1.131 828 1.320 896 1.696 727 1.210 369 1.191 557 0 0
Totale 28.256